In the case of HER2+ BC, different drugs directed against the HER2 receptor have proven to be effective in the treatment of advanced disease (63), including cerebral disease, sometimes avoiding aggressive surgery or brain irradiation with medium and long-term consequences. The gene discussed is ERBB2; the disease is breast cancer.